Learn about teprotumumab for moderate to severe thyroid eye disease, its benefits, risks, as well as evolving treatment ...

The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED).

Reports of cases detail the development of thyroid eye disease 3-5 years following treatment of MS with immunomodulatory ...

On June 26, 2026, Viridian Therapeutics announced that the U.S. Food and Drug Administration (“FDA”) approved LUMVOA™ (veligrotug-vvze) for ...

Backed by data from the phase 3 SatraGO trials, satralizumab has the potential to offer patients a convenient, at-home treatment option.

Top Cleveland Clinic and University of Iowa eye doctors point out that it's not just blurry vision or irritation—and not just ...

Thyroid eye disease is a chronic autoimmune disorder that inflames tissues behind the eye. Swelling can cause dry, irritated eyes, bulging, light sensitivity, and double vision. Thyroid eye disease ...

If you have dry eye, you know how uncomfortable it can be. Dry eye disease happens when your eyes do not make enough quality tears or when your tears dry out too quickly. This can lead to eye ...

Sponsored Content If your eyes often feel dry, irritated, or sensitive after a day spent looking at screens, you’re not alone ...

Multiple myeloma, a blood cancer, can lead to various eye problems due to complications such as hyperviscosity syndrome (thickened blood) or extramedullary disease (tumor growth outside the bone ...

Mild COVID-19 can cause severe and long-lasting eye problems, according to a study from Linköping University, Sweden. The ...